MedPath

Right Ventricle function in reversible pulmonary hypertensio

Not Applicable
Conditions
Health Condition 1: I260- Pulmonary embolism with acute corpulmonale
Registration Number
CTRI/2021/04/032885
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients diagnosed with hemodynamically significant acute PTE and CTEPH during study period will be included after informed written consent.

Exclusion Criteria

Patients who did not give consent

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the echocardiographic findings in patients with CTEPH and acute PTE and at follow up of six months after optimal management.Timepoint: To study the echocardiographic findings in patients with CTEPH and acute PTE and at follow up of six months after optimal management.
Secondary Outcome Measures
NameTimeMethod
To study the prevalence of PFO in patients presenting with acute PTE during study period <br/ ><br>To study the effect of PFO on clinical presentation of patients <br/ ><br>Timepoint: Six months of follow up
© Copyright 2025. All Rights Reserved by MedPath